P
PHAT
Phathom Pharmaceuticals, Inc.
11.87
0.02+0.17%Opening12:26 09/03 EDT
OPEN/PREV CLOSE11.79/11.85
TODAY RANGE11.62-12.04
VOL456.94K
MARKET CAP842.10M
52 WEEK RANGE2.210-19.71
AVG VOL (3M)2.31M
% TURNOVER0.64%
TURNOVER--
P/E (TTM)-2.5104
% RANGE3.50%
EPS(TTM)-4.7283
P/E(FORWARD)-3.5433
P/B-2.0504
BVPS-5.7890
DIVIDEND--
P/S14.72
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP656.68M
SHARES OUTSTANDING70.94M
NEXT EARNINGS11/05-11/10
FREE FLOAT55.32M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
TipRanks·08/20 12:06
Phathom clarifies no reduction in lead shareholder’s ownership amid 13D filing
Simply Wall St·08/15 10:11
Insider Sales At Phathom Pharmaceuticals Landed A Good Price
TipRanks·08/08 10:36
Phathom Pharmaceuticals (PHAT) Gets a Buy from H.C. Wainwright
TipRanks·08/08 05:20
Phathom Pharmaceuticals Reports Strong Q2 Growth
Seeking Alpha·08/08 02:52
Phathom projects $165M–$175M 2025 revenue as GI sales focus accelerates VOQUEZNA growth
TipRanks·08/07 19:16
Phathom Pharmaceuticals (PHAT) Gets a Buy from Guggenheim
TipRanks·08/07 14:19
Craig-Hallum Sticks to Its Buy Rating for Phathom Pharmaceuticals (PHAT)
Benzinga·08/07 13:48
Phathom Pharmaceuticals Sees FY2025 Sales $165.000M-$175.000M vs $159.818M Est
TipRanks·08/07 11:31
Phathom Pharmaceuticals sees 2025 revenue $165M-$175M, consensus $159.4M
Same Industry
Name/Symbol
Change%
Price